DICER1 and ovarian serous adenocarcinoma: The possible existence of miRNA-103/107-DICER axis, that had previously been described in the case of breast cancer, convinced us to perform a study dedicated to the clinical usefulness of miRNA-103/107 expression levels in high-grade serous ovarian cancer patients.